Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Olav Karsten Vintermyr"'
Autor:
Stian Tornaas, Dimitrios Kleftogiannis, Siren Fromreide, Hilde Ytre-Hauge Smeland, Hans Jørgen Aarstad, Olav Karsten Vintermyr, Lars Andreas Akslen, Daniela Elena Costea, Harsh Nitin Dongre
Publikováno v:
Heliyon, Vol 10, Iss 10, Pp e31191- (2024)
To decipher the interactions between various components of the tumor microenvironment (TME) and tumor cells in a preserved spatial context, a multiparametric approach is essential. In this pursuit, imaging mass cytometry (IMC) emerges as a valuable t
Externí odkaz:
https://doaj.org/article/6344f46aeae6447b80fe879f9f1b0eb1
Autor:
Øyvind Bruserud, Tor Henrik Anderson Tvedt, Aymen Bushra Ahmed, Olav Karsten Vintermyr, Tor Hervig, Anne Berit Guttormsen, Håkon Reikvam
Publikováno v:
Case Reports in Critical Care, Vol 2021 (2021)
Spontaneous splenic rupture is a life-threatening condition leading to a rapidly progressing hypovolemic shock due to intra-abdominal blood loss, with a mortality rate of about 10%. Spontaneous splenic rupture can be caused by widely different disord
Externí odkaz:
https://doaj.org/article/32641b9a406f469d979b5b4a875d6e78
Autor:
Helene Hersvik Aarstad, Olav Karsten Vintermyr, Elling Ulvestad, Kenneth Kross, John Helge Heimdal, Hans Jorgen Aarstad
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129724 (2015)
The study was performed in order to determine whether peripheral blood monocyte in vitro function, and lymphocyte in vivo activation at diagnosis, was associated with HPV tumor infection status and 15-year survival in head and neck squamous cell carc
Externí odkaz:
https://doaj.org/article/354fa1328f97499a98240623dd1618fa
Autor:
Christina Engebrethsen, Synnøve Yndestad, Andrea Herencia-Ropero, Oleksii Nikolaienko, Olav Karsten Vintermyr, Reidun K. Lillestøl, Laura Minsaas, Beryl Leirvaag, Gjertrud Iversen, Bjørnar Gilje, Egil Blix, Helge Espelid, Steinar Lundgren, Jürgen Geisler, Liv Jorunn Vassbotn, Hildegunn S. Aase, Turid Aas, Alba Llop-Guevara, Violeta Serra, Per Eystein Lønning, Stian Knappskog, Hans Petter Eikesdal
Publikováno v:
Cancer Research. 83:P6-10
Background: Homologous recombination deficiency (HRD) is highly prevalent in triple-negative breast cancer (TNBC) and predictive of response to PARP inhibition in the primary setting (Eikesdal et al, Ann Oncol, 2021). However, the prevalence of HRD a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67aa0b67fcf877e78088d27a860fa691
https://doi.org/10.1158/1538-7445.sabcs22-p6-10-04
https://doi.org/10.1158/1538-7445.sabcs22-p6-10-04
Autor:
Hege Elvebakken, Geir Olav Hjortland, Herish Garresori, Per Arne Andresen, Emiel A. M. Janssen, Olav Karsten Vintermyr, Inger M. B. Lothe, Halfdan Sorbye
Publikováno v:
Journal of Neuroendocrinology. 35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21a59bc1dce355eb9de2865f8972209b
https://doi.org/10.1111/jne.13256
https://doi.org/10.1111/jne.13256
Autor:
Stian Tornaas, Dimitrios Kleftogiannis, Siren Fromreide, Hilde Ytre-Hauge Smeland, Hans Jørgen Aarstad, Olav Karsten Vintermyr, Lars A. Akslen, Daniela Elena Costea, Harsh Dongre
IntroductionCancer associated fibroblast (CAF) mediated crosstalk with other tumor compartments is shown to modulate cancer development and progression. Conventionally, CAFs are known to promote tumorigenesis either by secreting a wide range of growt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2d62d2a1c125c71f1acce715082e90a
https://doi.org/10.1101/2022.05.12.491175
https://doi.org/10.1101/2022.05.12.491175
Autor:
Mari Nygård, Birgit Engesæter, Philip E. Castle, Jannicke Mohr Berland, Maj Liv Eide, Ole Erik Iversen, Christine Monceyron Jonassen, Irene Kraus Christiansen, Olav Karsten Vintermyr, Ameli Tropé
Publikováno v:
Cancer Epidemiology, Biomarkers and Prevention
Background: Cervical cancer screening programs are facing a programmatic shift where screening protocol based on human papillomavirus testing (HPV-Screening protocol) is replacing the liquid-based cytology (LBC-Screening protocol). For safe technolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c953fd3858ac61811d3a4660b37a3d7
https://hdl.handle.net/11250/3022883
https://hdl.handle.net/11250/3022883
Autor:
Saroj Rajthala, Kristin Marie Hoven, Anne Christine Johannessen, Arild Kvalheim, Stein Lybak, Dipak Sapkota, Borghild Ljøkjel, Anjie Min, Himalaya Parajuli, Daniela Elena Costea, Kala Chand Debnath, Olav Karsten Vintermyr, Evelyn Neppelberg
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 11960, p 11960 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 21
International Journal of Molecular Sciences
Volume 22
Issue 21
Background: Knowledge on the role of miR changes in tumor stroma for cancer progression is limited. This study aimed to investigate the role of miR dysregulation in cancer-associated fibroblasts (CAFs) in oral squamous cell carcinoma (OSCC). Methodol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d6345e58121fc085bc580ad6814854d
https://hdl.handle.net/11250/2831794
https://hdl.handle.net/11250/2831794
Autor:
Tor Hervig, Håkon Reikvam, Anne Berit Guttormsen, Olav Karsten Vintermyr, Øyvind Bruserud, Aymen Bushra Ahmed, Tor Henrik Anderson Tvedt
Publikováno v:
Case Reports in Critical Care
Case Reports in Critical Care, Vol 2021 (2021)
Case Reports in Critical Care, Vol 2021 (2021)
Spontaneous splenic rupture is a life-threatening condition leading to a rapidly progressing hypovolemic shock due to intra-abdominal blood loss, with a mortality rate of about 10%. Spontaneous splenic rupture can be caused by widely different disord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba1d87c617e78f78cca2c4e6731778d
https://hdl.handle.net/11250/2990191
https://hdl.handle.net/11250/2990191
Autor:
Helge Espelid, Stian Knappskog, Alba Llop-Guevara, Judith Balmaña, Beryl Leirvaag, Jürgen Geisler, Bjørnar Gilje, Laura Minsaas, Asmaa Elzawahry, Steinar Lundgren, Olav Karsten Vintermyr, Egil S. Blix, Per Eystein Lønning, Synnøve Yndestad, Geirfinn Vagstad, Emiel A. M. Janssen, Hildegunn Siv Aase, Andreas Venizelos, Hans Petter Eikesdal, Violeta Serra, Einar Gudlaugsson, Turid Aas
Publikováno v:
Annals of Oncology
Background The antitumor efficacy of PARP inhibitors (PARPi) for breast cancer patients harboring germline BRCA1/2 (gBRCA1/2) mutations is well established. While PARPi monotherapy was ineffective in patients with metastatic triple negative breast ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71c4233c7a23662c06d637156987fe9c
https://hdl.handle.net/10037/20445
https://hdl.handle.net/10037/20445